Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

The past week in the industry has brought much hope for patients with the news of significant research data developments …
News
thomas_headshot

BMS finds replacement for retiring CSO

March 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb

Bristol-Myers Squibb has announced the appointment of Dr. Thomas J. Lynch, Jr., to the position of Executive Vice President and …
Appointment

Novo Nordisk eyes acquisition of Global Blood Therapeutics

March 9, 2017 Sales and Marketing Global Blood Therapeutics, Novo Nordisk

Novo Nordisk has been notoriously shy when it comes to making acquisitions but Reuters has reported that this may be …
News
trevor-philips

Vectura’s COO set to step down

March 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing vectura

Vectura’s Chief Operating Officer, Trevor Phillips, will step down from the board on 25 May before leaving the company on …
Appointment
amgen_hq

FDA and NICE approve of first new hyperparathyroidism drug in 12 years

March 8, 2017 Research and Development, Sales and Marketing FDA, NICE, Parsabiv, hyperparathyroidism

The FDA has given the go-ahead for Amgen’s hyperparathyroidism (HPT) therapy Parsabiv (etelcalcetide), marking the first new treatment for patients …
News
shutterstock_92671375

Cadila and Supernus settle patent dispute over epilepsy generic

March 7, 2017 Manufacturing and Production, Sales and Marketing Cadila, Supernus, Trokendi XR, Zydus Cadila

A patent dispute between Indian pharmaceutical firm Cadila Healthcare and US-based Supernus Pharmaceuticals has been ended with legal calls for …
News
bernie_2

Vermont senators call for restraints on “beautiful” pharma advertising

March 6, 2017 Manufacturing and Production, Sales and Marketing Bernie Sanders, Vermont, pricing

Bernie Sanders is yet again leading the charge against US pharma as Vermont senators have rallied against advertising and marketing …
News
europe_tied_in_knots

Negotiating the EU pricing system: How the financial crisis has encouraged closer-knit cooperation between member states

March 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Europe, pricing

Drug pricing is a topic that has become headline-friendly over the past year. It has come to dominate media coverage …
Feature

Lilly posts impressive psoriasis results in comparison study

March 6, 2017 Research and Development, Sales and Marketing J&J, JJ, Stelara, Taltz, lilly

Eli Lilly has revealed strong results in a study comparing its psoriasis treatment, Taltz (ixekizumab), to Johnson & Johnson’s Stelara. …
News
mediaphoto7_large

Cipla halts HIV drug production due to delayed government funding

March 6, 2017 Sales and Marketing Cipla, HIV, India, Lopinavir

Indian pharmaceutical company Cipla has halted production of its child-friendly antiretroviral HIV treatment Lopinavir (ABT-378) due to the failure by …
News
abbvie_0

UK High Court rules against AbbVie’s Humira patents

March 6, 2017 Sales and Marketing AbbVie, Biogen, Fujifilm Kyowa Kirin Biologics, Humira, Samsung Bioepis, biosimilar

The UK High Court has ruled that two of AbbVie patents, related to dosing regimens for rheumatoid arthritis, psoriasis and …
News
janssen_latest_logo_on_sign_closer

Phase 3 data for Janssen psoriasis drug shows efficacy over Humira

March 6, 2017 Research and Development, Sales and Marketing Humira, Janssen, guselkumab, psoriasis

Janssen has revealed new Phase 3 data for its human monoclonal antibody guselkumab in the treatment of adults with moderate …
News
otsuka_holdings_logo

Otsuka to acquire Neurovance in potential $250 million deal

March 6, 2017 Sales and Marketing ADHD, Neurovance, Otsuka Pharmaceuticals

Otsuka Pharmaceuticals, a pharmaceutical firm with headquarters in Japan, has agreed to pay a potential $250 million in a deal …
News

Bioverativ adds new member to board of directors

March 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Biogen spinout, Bioverativ, have moved to consolidate its board of directors by appointing Anna Protopapas to the board. Protopapas becomes …
Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s been a busy week on Pharmafile.com over the last seven days. Europe’s first biosimilar treatment for cancer continues to …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026